TDC
MTEM

Thompson Davis & Co’s Molecular Templates, Inc. MTEM Stock Holding History

Thompson Davis & Co’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$1K Buy
+17
New +$1.3K ﹤0.01% 698

Other funds holding MTEM

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Thompson Davis & Co's MTEM Position: Q3 2018 in Review

Thompson Davis & Co opened a new position in Molecular Templates, Inc. (MTEM) in Q3 2018: 17 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #698 among its holdings.

62 funds tracked by Wall St. Rank hold MTEM as of Q3 2018.

  • Thompson Davis & Co held 17 shares of Molecular Templates, Inc. worth $1K as of Q3 2018.
  • Molecular Templates, Inc. was a new Thompson Davis & Co position in Q3 2018.
  • Molecular Templates, Inc. made up ﹤0.01% of Thompson Davis & Co's portfolio in Q3 2018, its #698 holding.
  • 62 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.